Brief: Molecular Templates Announces Partial Clinical Hold For Phase 1 Study Of MT-0169
07/04/2023 23:54
April 7 (Reuters) - Molecular Templates Inc MTEM.O :
* MOLECULAR TEMPLATES ANNOUNCES PARTIAL CLINICAL HOLD FOR
PHASE 1
STUDY OF MT-0169
Source text for Eikon: ID:nGNX2ZhpSQ
Further company coverage: MTEM.O
((Reuters.briefs@thomsonreuters.com;))
Recent news on Molecular Templates
See all newsBrief: Molecular Templates Co & Affiliate Commenced Chapter 11 Cases As DIP
Brief: Molecular Templates's Eric E. Poma Resigns As CEO, CSO, Treasurer, And Interim CFO
Brief: Molecular Templates Announces Notice Of Delisting And Failure To Satisfy Continued Listing Rules
Brief: Molecular Templates Announces Receipt Of Expected Notification Of Deficiency From Nasdaq
Brief: Molecular Templates Approved Liquidation & Wind Up Through A Dissolution